Common Contracts
4 similar Employment Agreement contracts by PPD, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2020 • PPD, Inc. • Services-commercial physical & biological research • North Carolina
This Employment Agreement (this “Agreement”), dated as of April 10, 2012 (the “Effective Date”), is made by and between Pharmaceutical Product Development, LLC, a Delaware limited liability company (together with any successor thereto, the “Company”), and B. Judd Hartman (the “Executive” and, together with the Company, the “Parties”) and, solely with respect to Section 9(n), Jaguar Holding Company I, a Delaware corporation (“Parent”). Where the context requires, references herein to the “Company” include Pharmaceutical Product Development, Inc., a North Carolina corporation and predecessor to the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2020 • PPD, Inc. • Services-commercial physical & biological research • North Carolina
This Employment Agreement (this “Agreement”), dated as of April 10, 2012 (the “Effective Date”), is made by and between Pharmaceutical Product Development, LLC, a Delaware limited liability company (together with any successor thereto, the “Company”), and William J. Sharbaugh (the “Executive” and, together with the Company, the “Parties”) and, solely with respect to Sections 9(l)(vii) 9(n), Jaguar Holding Company I, a Delaware corporation (“Parent”). Where the context requires, references herein to the “Company” include Pharmaceutical Product Development, Inc., a North Carolina corporation and predecessor to the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2020 • PPD, Inc. • Services-commercial physical & biological research • North Carolina
This Employment Agreement (this “Agreement”), entered into on May 2, 2018 and effective for employment as of May 15, 2018 (the “Effective Date”), is made by and between Pharmaceutical Product Development, LLC, a Delaware limited liability company (together with any successor thereto, the “Company”), and Christopher G. Scully (“Executive” and, together with the Company, the “Parties”) and, solely with respect to Sections 1(c), 2(h), 9(m) and 9(n), Eagle Holding Company I, a Delaware corporation (“Parent”). Where the context requires, references herein to the “Company” include Pharmaceutical Product Development, Inc., a North Carolina corporation and predecessor to the Company. For the avoidance of doubt, this Agreement is binding on the Company and Executive on the date it is fully executed by both parties.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 16th, 2020 • PPD, Inc. • Services-commercial physical & biological research • North Carolina
This Amended and Restated Employment Agreement (this “Agreement”), dated as of November 26, 2019 and effective as of November 1, 2019 (the “Effective Date”), is made by and between Pharmaceutical Product Development, LLC, a Delaware limited liability company (together with any successor thereto, the “Company”), and Anshul Thakral (the “Executive” and, together with the Company, the “Parties”) and, solely with respect to Sections 2(g), 9(m) and 9(n), Eagle Holding Company I, a Delaware corporation (“Parent”). Where the context requires, references herein to the “Company” include Pharmaceutical Product Development, Inc., a North Carolina corporation and predecessor to the Company. For the avoidance of doubt, this Agreement is binding on the Company and Executive on the date it is fully executed by both parties.
